SWITCHING OF BIOLOGICAL DRUGS IN RHEUMATOID ARTHRITIS: A COHORT OF USERS FROM THE BRAZILIAN PUBLIC HEALTH SYSTEM

被引：0
|
作者：
Matute, D. L. [1 ]
Galvao, T. F. [2 ]
Mota, L. M. [3 ]
Pereira, M. G. [3 ]
Silva, M. T. [4 ]
机构：
[1] Univ Fed Amazonas, Manaus, Amazonas, Brazil
[2] Univ Estadual Campinas, Campinas, SP, Brazil
[3] Univ Brasilia, Brasilia, DF, Brazil
[4] Univ Sorocaba, Sorocaba, Brazil
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2984
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS25
引用
收藏
页码：A939 / A939
页数：1
相关论文
共 50 条
  • [11] HOSPITAL ADMISSIONS FOR RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY POLYARTHROPATHIES IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Dal Pra Wendt, A.
    Milene Cardozo, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1440 - 1441
  • [12] Academic detailing program for rheumatoid arthritis: a contribution to Brazilian public health system sustainability
    Carvalho Borin, Marcus
    Kakehasi, Adriana Maria
    Dartnell, Jonathan
    Ribeiro Junior, Nelio Gomes
    Acurcio, Francisco de Assis
    Guerra Junior, Augusto Afonso
    Alvares-Teodoro, Juliana
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2020, 11 (03) : 249 - 254
  • [13] Drugs for rheumatoid arthritis provided by the Unified Health System in 2019 in Brazil: a cohort study
    Oliveira, Ana Liani Beisl
    Lima, Elisangela Costa
    Campos, Monica
    Luiza, Vera Lucia
    CIENCIA & SAUDE COLETIVA, 2023, 28 (05): : 1443 - 1456
  • [14] ESTIMATING THE BUDGET IMPACT IN BRAZILIAN PUBLIC HEALTH CARE SYSTEM OF TOCILIZUMAB REIMBURSEMENT AS A RHEUMATOID ARTHRITIS FIRST-LINE BIOLOGICAL THERAPY
    Tsuchiya, C. T.
    Tobaruella, F. S.
    Ramos, L. A.
    Buschinelli, C. T.
    Maximo, M. F. M.
    Goncalves, T. M.
    VALUE IN HEALTH, 2013, 16 (07) : A715 - A715
  • [15] Profile of users of drugs for the treatment of chronic hepatitis B available through the Brazilian Public Health System
    Wiens, Astrid
    Lenzi, Luana
    Grochocki, Monica Cavichiolo
    Correr, Cassyano Januario
    Pontarolo, Roberto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (04): : 379 - 382
  • [16] ECONOMIC BURDEN OF RHEUMATOID ARTHRITIS IN BRAZILIAN PRIVATE HEALTH SYSTEM
    Vogel, S.
    Marante, T. R.
    Monteiro, R.
    VALUE IN HEALTH, 2009, 12 (07) : A524 - A524
  • [17] BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS: REAL LIFE DATA IN A BRAZILIAN MULTICENTRIC STUDY
    Gomides, A.
    Pinheiro, G.
    Santos, A.
    Albuquerque, C.
    Giorgi, R.
    Radominski, S.
    Pereira, I.
    Guimaraes, M.
    Bertolo, M.
    Junior, P. L.
    Bonfiglioli, K.
    Brenol, C.
    Cunha, M.
    Mota, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1372 - 1373
  • [18] Biological drugs for the treatment of psoriasis in a public health system
    Lopes, Luciane Cruz
    do Nascimento Silveira, Miriam Sanches
    de Camargo, Iara Alves
    Barberato-Filho, Silvio
    Del Fioli, Fernando de Sa
    Serpa Osorio-de-Castro, Claudia Garcia
    REVISTA DE SAUDE PUBLICA, 2014, 48 (04): : 651 - 661
  • [19] COST-MINIMIZATION ANALYSIS AND BUDGET IMPACT OF UPADACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN THE BRAZILIAN PUBLIC HEALTH SYSTEM
    Acayaba de Toledo, R.
    Arruda, M. S.
    Morais, C. G., V
    dos Santos, R.
    VALUE IN HEALTH, 2021, 24 : S16 - S17
  • [20] Epidemiology and treatment of patients with rheumatoid arthritis in the Brazilian public health system: A real-world evidence study
    Ribeiro, Tatiane B.
    Valverde, Douglas Andreas
    Firmiano, Elcio
    Giannotti Cousseau, Tathyana Christiano
    Azevedo, Valderilio Feijo
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 213 - 213
12345